Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 4 (2007), Issue 2 (February)

1. Management of AIDS-related Kaposi's sarcoma.
   Lancet Oncol, 8(2): 167-76. [Abstract] [Full-text]
2. Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction.
   Biotechnol Bioeng, 96(4): 795-802. [Abstract] [Full-text]
3. Cataract surgery is associated with a higher rate of photodynamic therapy for age-related macular degeneration.
   Ophthalmology, 114(2): 278-82. [Abstract] [Full-text]
4. Treatment of lymphangioma in children: our experience of 128 cases.
   J Pediatr Surg, 42(2): 386-9. [Abstract] [Full-text]
5. Combined targeted therapies in non-small cell lung cancer: a winner strategy?
   Curr Opin Oncol, 19(2): 98-102. [Abstract] [Full-text]
6. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.
   Biochem Pharmacol, 73(5): 620-31. [Abstract] [Full-text]
7. Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion.
   Cancer Immunol Immunother, 56(4): 573-80. [Abstract] [Full-text]
8. Sexual sequelae of general medical disorders.
   Lancet, 369(9559): 409-24. [Abstract] [Full-text]
9. Photodynamic treatment of cutaneous leishmaniasis.
   J Dtsch Dermatol Ges, 5(2): 128-30. [Abstract] [Full-text]
10. Meta-analysis of published data on incompletely excised basal cell carcinomas of the ear and nose with introduction of an innovative treatment strategy.
    J Dtsch Dermatol Ges, 5(2): 118-26. [Abstract] [Full-text]
11. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth.
    Fertil Steril, 87(2): 418.e7-418.e15. [Abstract] [Full-text]
12. Testosterone replacement increases vasodilatory reserve in androgen-deficient female rats.
    Fertil Steril, 87(2): 422-5. [Abstract] [Full-text]
13. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.
    Clin Infect Dis, 44(5): 726-34. [Abstract] [Full-text]
14. Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response.
    Int J Cancer, 120(7): 1579-90. [Abstract] [Full-text]
15. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery.
    Biomaterials, 28(11): 2041-50. [Abstract] [Full-text]
16. Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier.
    Biomaterials, 28(11): 2061-7. [Abstract] [Full-text]
17. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study.
    Circulation, 115(5): 576-83. [Abstract] [Full-text]
18. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study.
    J Natl Cancer Inst, 99(3): 206-14. [Abstract] [Full-text]
19. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    J Natl Cancer Inst, 99(3): 196-205. [Abstract] [Full-text]
20. Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study.
    Br J Cancer, 96(3): 439-44. [Abstract] [Full-text]
21. Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer.
    Br J Cancer, 96(3): 432-8. [Abstract] [Full-text]
22. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.
    Blood, 109(4): 1408-13. [Abstract] [Full-text]
23. Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo.
    Oncogene, 26(6): 905-16. [Abstract] [Full-text]
24. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.
    J Clin Oncol, 25(5): 526-31. [Abstract] [Full-text]
25. Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
    J Clin Oncol, 25(5): 513-6. [Abstract] [Full-text]
26. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
    J Clin Oncol, 25(5): 501-6. [Abstract] [Full-text]
27. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
    J Clin Oncol, 25(5): 493-500. [Abstract] [Full-text]
28. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
    Biomaterials, 28(12): 2137-46. [Abstract] [Full-text]
29. Sequential chemotherapy in nonsmall-cell lung cancer: cisplatin and gemcitabine followed by docetaxel.
    Cancer, 109(4): 727-31. [Abstract] [Full-text]
30. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Cancer, 109(4): 751-60. [Abstract] [Full-text]
31. Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first-line therapy in advanced nonsmall cell lung cancer.
    Cancer, 109(4): 732-40. [Abstract] [Full-text]
32. CT appearances of talc pleurodesis.
    Clin Radiol, 62(3): 233-7. [Abstract] [Full-text]
33. Preparation of thin polymer films with drug release and protein adsorption resistance.
    Colloids Surf B Biointerfaces, 55(1): 19-25. [Abstract] [Full-text]
34. Is antibiotic prophylaxis necessary in infants with obstructive hydronephrosis?
    J Urol, 177(3): 1098-101; discussion 1101. [Abstract] [Full-text]
35. PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice.
    Int J Pharm, 331(2): 228-32. [Abstract] [Full-text]
36. Programmable delivery of hydrophilic drug using dually responsive hydrogel cages.
    J Control Release, 117(3): 396-402. [Abstract] [Full-text]
37. Inhibition of transferrin iron release increases in vitro drug carrier efficacy.
    J Control Release, 117(3): 403-12. [Abstract] [Full-text]
38. Construction of nanoscale multicompartment liposomes for combinatory drug delivery.
    Int J Pharm, 331(2): 182-5. [Abstract] [Full-text]
39. Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems.
    J Control Release, 117(3): 333-41. [Abstract] [Full-text]
40. A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice.
    J Control Release, 117(3): 342-50. [Abstract] [Full-text]
41. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
    Int J Pharm, 331(2): 190-6. [Abstract] [Full-text]
42. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.
    Int J Pharm, 331(2): 153-9. [Abstract] [Full-text]
43. Liposomes for phospholipase A2 triggered siRNA release: preparation and in vitro test.
    Int J Pharm, 331(2): 160-6. [Abstract] [Full-text]
44. Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers.
    Int J Pharm, 331(2): 148-52. [Abstract] [Full-text]
45. Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro.
    Int J Pharm, 331(2): 224-7. [Abstract] [Full-text]
46. Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes.
    Int J Pharm, 331(2): 186-9. [Abstract] [Full-text]
47. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
    Int J Pharm, 331(2): 167-75. [Abstract] [Full-text]
48. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
    Biomaterials, 28(13): 2220-32. [Abstract] [Full-text]
49. Serum C-reactive protein concentrations in dogs with multicentric lymphoma undergoing chemotherapy.
    J Am Vet Med Assoc, 230(4): 522-6. [Abstract] [Full-text]
50. Symptomatic intracranial haemorrhage after intra-arterial thrombolysis in acute ischaemic stroke: assessment of 294 patients treated with urokinase.
    J Neurol Neurosurg Psychiatry, 78(3): 280-5. [Abstract] [Full-text]
51. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
    Cancer Res, 67(4): 1716-24. [Abstract] [Full-text]
52. Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.
    Cancer Res, 67(4): 1430-5. [Abstract] [Full-text]
53. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.
    Am Heart J, 153(3): 439-44. [Abstract] [Full-text]
54. The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration.
    J Neurol Neurosurg Psychiatry, 78(3): 233-9. [Abstract] [Full-text]
55. Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer.
    Gynecol Oncol, 104(3): 612-6. [Abstract] [Full-text]
56. Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma.
    Gynecol Oncol, 104(3): 580-5. [Abstract] [Full-text]
57. In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer.
    Gynecol Oncol, 104(3): 596-601. [Abstract] [Full-text]
58. Hormonal influence on periurethral vessels in postmenopausal incontinent women using Doppler velocimetry analysis.
    Maturitas, 56(3): 297-302. [Abstract] [Full-text]
59. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
    Maturitas, 56(3): 231-48. [Abstract] [Full-text]
60. Dry eye in post-menopausal women using hormone replacement therapy.
    Maturitas, 56(3): 257-62. [Abstract] [Full-text]
61. Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.
    Cancer Chemother Pharmacol, 59(5): 613-20. [Abstract] [Full-text]
62. Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.
    Cancer Chemother Pharmacol, 59(5): 621-9. [Abstract] [Full-text]
63. Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?
    Cancer Chemother Pharmacol, 59(5): 637-42. [Abstract] [Full-text]
64. Evolution of OGTT in patients with beta-thalassaemia major in relation to chelation therapy.
    Diabetes Res Clin Pract, 76(1): 6-11. [Abstract] [Full-text]
65. A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer.
    Cancer Chemother Pharmacol, 59(5): 631-6. [Abstract] [Full-text]
66. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Circulation, 115(7): 840-5. [Abstract] [Full-text]
67. Docetaxel/anthracycline combinations for breast cancer treatment.
    Expert Opin Pharmacother, 8(4): 485-95. [Abstract] [Full-text]
68. Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.
    Blood, 109(5): 1862-9. [Abstract] [Full-text]
69. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Blood, 109(5): 1857-61. [Abstract] [Full-text]
70. Does sustained epinephrine release trigger a hypoxia-neovascularization cascade?
    Plast Reconstr Surg, 119(3): 858-64. [Abstract] [Full-text]
71. The effects of clonidine on postoperative analgesia after peripheral nerve blockade in children.
    Anesth Analg, 104(3): 532-7. [Abstract] [Full-text]
72. Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies.
    J Am Acad Child Adolesc Psychiatry, 46(3): 309-22. [Abstract] [Full-text]
73. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
    Am J Ophthalmol, 143(3): 449-54. [Abstract] [Full-text]
74. Off-label prescribing in a French hospital.
    Pharm World Sci, 29(2): 97-100. [Abstract] [Full-text]
75. Using bar-code technology and medication observation methodology for safer medication administration.
    Am J Health Syst Pharm, 64(5): 536-43. [Abstract] [Full-text]
76. Medication-error reporting and pharmacy resident experience during implementation of computerized prescriber order entry.
    Am J Health Syst Pharm, 64(5): 526-30. [Abstract] [Full-text]
77. Pleurodesis with an autologous blood patch to prevent persistent air leaks after lobectomy.
    J Thorac Cardiovasc Surg, 133(3): 759-62. [Abstract] [Full-text]
78. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
    Biochim Biophys Acta, 1770(4): 681-6. [Abstract] [Full-text]
79. Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg).
    Int J Oral Maxillofac Surg, 36(4): 321-7. [Abstract] [Full-text]
80. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Dent Mater, 23(4): 404-9. [Abstract] [Full-text]
81. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.
    Stroke, 38(3): 948-54. [Abstract] [Full-text]
82. The impact of recanalization on ischemic stroke outcome: a meta-analysis.
    Stroke, 38(3): 967-73. [Abstract] [Full-text]
83. High-density lipoprotein cholesterol: an emerging target for stroke treatment.
    Stroke, 38(3): 1104-9. [Abstract] [Full-text]
84. A comparison of percutaneous coronary intervention and surgical revascularization after fibrinolysis for acute myocardial infarction. Insights from the InTIME-2 trial.
    Int J Cardiol, 116(3): 383-8. [Abstract] [Full-text]
85. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Pediatr Blood Cancer, 48(4): 408-15. [Abstract] [Full-text]
86. Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy.
    Pediatr Blood Cancer, 48(4): 435-40. [Abstract] [Full-text]
87. Pediatric primary leptomeningeal lymphoma treated without cranial radiotherapy.
    Pediatr Blood Cancer, 48(4): 477-8. [Abstract] [Full-text]
88. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.
    J Clin Oncol, 25(7): 837-44. [Abstract] [Full-text]
89. Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.
    J Clin Oncol, 25(7): 773-80. [Abstract] [Full-text]
90. Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
    J Clin Oncol, 25(7): 793-8. [Abstract] [Full-text]
91. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
    J Clin Oncol, 25(7): 787-92. [Abstract] [Full-text]
92. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target.
    Nat Methods, 4(3): 269-79. [Abstract] [Full-text]
93. Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.
    J Acquir Immune Defic Syndr, 44(3): 262-7. [Abstract] [Full-text]
94. Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.
    J Acquir Immune Defic Syndr, 44(3): 286-91. [Abstract] [Full-text]
95. Development of novel poly(ethylene glycol)-based vehicles for gene delivery.
    Biotechnol Bioeng, 96(5): 967-76. [Abstract] [Full-text]
96. Alginate microparticles as novel carrier for oral insulin delivery.
    Biotechnol Bioeng, 96(5): 977-89. [Abstract] [Full-text]

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.